Pfizer Has A Cold: Here's The Trade –

This post was originally published on this site

Since March 1, 2019, pharmaceutical giant Pfizer (NYSE:) has been selling off on the charts. The stock is now testing its 200-day moving average, around the $41.50 area. Traders should note that if the stock breaks its recent low at $40.34, it will signal another move lower in the shares.

Support Watch

The next important support level for PFE is around $37.80. This area should be defended when it is initially tested as it is the 100-weekly moving average and an area where the stock broke out in late July 2018.

Pfizer Inc.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

This post was originally published on *this site*